Chlamydia pneumoniae and the Risk for Exacerbation in Multiple Sclerosis Patients

Annals of Neurology

Volumn 54, Issue 6, 2003, Pages 828-831

  Buljevac, Dragan ^a   Verkooyen, Roel P ^a   Jacobs, Bart C ^a   Hop, Wim ^a   Van Der Zwaan, Liesbeth A ^a   Van Doorn, Pieter A ^a   Hintzen, Rogier Q ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SEROLOGY;

ADULT; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PNEUMONIA; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0345095269     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10759     Document Type: Article

References (20)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-952.
2. Buljevac D, Flach HZ, Hop WC, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002;125:952-960.
3. Panitch HS. Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 1994;36(suppl):S25-S28.
4. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-461.
5. Sriram S, Mitchell W, Stratton C. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 1998;50:571-572.
6. Jacobson S, Cross A. Association of Chlamydia pneumoniae and multiple sclerosis: stage two? Neurology 2001;56:1128-1129.
7. Ekman MR, Leinonen M, Syrjala H, et al. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 1993;12:756-760.
8. Verkooyen RP, Van Lent NA, Mousavi Joulandan SA, et al. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by microimmunofluorescence and ELISA. J Med Microbiol 1997;46:959-964.
9. Verkooyen RP, Peeters MF, Rijsoort-Vos JH, et al. Sensitivity and specificity of three new commercially available Chlamydia trachomatis tests. Int J STD AIDS 2002;13(suppl):23-25.
10. Valtonen JM, Syrjala MT, Valtonen VV. Association between high antistaphylolysin and teichoic acid antibody titers with rheumatic syndromes. Clin Rheumatol 1997;16:557-561.
11. Boman J, Allard A, Persson K, et al. Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA. J Infect Dis 1997;175:1523-1526.
12. Schumacher GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965;122:552-568.
13. Verkooyen RP, Willemse D, Hiep-van Casteren SC, et al. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Clin Microbiol 1998;36:2301-2307.
14. Berdal BP, Scheel O, Ogaard AR, et al. Spread of subclinical Chlamydia pneumoniae infection in a closed community. Scand J Infect Dis 1992;24:431-436.
15. Gnarpe H, Gnarpe J, Lundback A. Evidence of 2 waves of Chlamydia pneumoniae infection in Gavle, Sweden, 1990-96. Scand J Infect Dis 1999;31:83-86.
16. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998;11:345-349.
17. Lenz DC, Lu L, Conant SB, et al. A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats. J Immunol 2001;167:1803-1808.
18. Du C, Yao SY, Ljunggren-Rose A, Sriram S. Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis. J Exp Med 2002;196:1639-1644.
19. Janeway CA Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
20. Lehnardt S, Lachance C, Patrizi S, et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 2002;22:2478-2486.